GTEX-1KD4Q
|
41-50
|
Male
|
GTEX-1KD4Q-1526 |
Liver
|
PAXgene |
2
|
2 pieces; slight degree of congestion
|
Acceptable
|
|
GTEX-1KD5A
|
51-60
|
Male
|
GTEX-1KD5A-1226 |
Liver
|
PAXgene |
1
|
2 pieces; mild to moderate steatosis
|
Acceptable
|
|
GTEX-1KWVE
|
21-40
|
Male
|
GTEX-1KWVE-0326 |
Liver
|
PAXgene |
1
|
2 pieces; central vein congestion
|
Acceptable
|
|
GTEX-1LB8K
|
51-60
|
Male
|
GTEX-1LB8K-1926 |
Liver
|
PAXgene |
1
|
2 pieces; moderate macrovesicular steatosis, cord cell damage, chronic inflammation and bridging fibrosis consistent with steatohepatitis
|
Acceptable
|
|
GTEX-1LC47
|
61-70
|
Male
|
GTEX-1LC47-1326 |
Liver
|
PAXgene |
1
|
2 pieces, establishc cirrhosis and diffuse macrovesicular steatosis
|
Acceptable
|
|
GTEX-1LG7Y
|
51-60
|
Male
|
GTEX-1LG7Y-0726 |
Liver
|
PAXgene |
1
|
2 pieces, mild passive congestion
|
Acceptable
|
|
GTEX-1LGRB
|
51-60
|
Female
|
GTEX-1LGRB-0626 |
Liver
|
PAXgene |
1
|
2 pieces; severe steatosis with mild chronic inflammation, Mallory's hyaline, consistent with history of alcohol abuse
|
Acceptable
|
|
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-0926 |
Liver
|
PAXgene |
1
|
2 pieces, moderate passive congestion
|
Acceptable
|
|
GTEX-1LKK1
|
51-60
|
Female
|
GTEX-1LKK1-1026 |
Liver
|
PAXgene |
3
|
2 pieces, advanced cirrhosis, advanced autolysis
|
Acceptable
|
|
GTEX-1LSNL
|
51-60
|
Male
|
GTEX-1LSNL-2026 |
Liver
|
PAXgene |
1
|
2 pieces, moderate macrovesicular steatosis, ~30% of parenchyma; early bridging fibrosis
|
Acceptable
|
|
GTEX-1LSVX
|
61-70
|
Male
|
GTEX-1LSVX-0926 |
Liver
|
PAXgene |
2
|
2 pieces; extensive centrilobular sinusoidal congestion with cord cell loss
|
Acceptable
|
|
GTEX-1LVA9
|
51-60
|
Male
|
GTEX-1LVA9-1826 |
Liver
|
PAXgene |
1
|
2 pieces; include capsule (target is 1cm below capsule), central congestion
|
Acceptable
|
|
GTEX-1LVAO
|
61-70
|
Male
|
GTEX-1LVAO-1126 |
Liver
|
PAXgene |
1
|
2 pieces; several bile duct hamartomas occupy 5%
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-0926 |
Liver
|
PAXgene |
1
|
2 pieces, macrovesicular steatosis in ~10% of parenchyma. Focal areas approach autolysis score 2
|
Acceptable
|
|
GTEX-1MA7X
|
61-70
|
Male
|
GTEX-1MA7X-0526 |
Liver
|
PAXgene |
2
|
2 pieces; occasional portal lymphoid collections; no cirrhosis; poorly preserved and fragmented parenchyma
|
Acceptable
|
|
GTEX-1MCQQ
|
51-60
|
Male
|
GTEX-1MCQQ-0526 |
Liver
|
PAXgene |
2
|
2 pieces; no fibrosis, inflammation or fat
|
Acceptable
|
|
GTEX-1MJIX
|
41-50
|
Male
|
GTEX-1MJIX-0726 |
Liver
|
PAXgene |
1
|
2 pieces; 1 piece includes portion of capsule (target region is 1cm below), steatosis
|
Acceptable
|
|
GTEX-1MJK2
|
51-60
|
Male
|
GTEX-1MJK2-0626 |
Liver
|
PAXgene |
1
|
2 pieces; mild microvesicular steatosis; marked congestion
|
Acceptable
|
|
GTEX-1N2DW
|
51-60
|
Male
|
GTEX-1N2DW-1326 |
Liver
|
PAXgene |
1
|
2 pieces; congestion and cardiac sclerosis ("cirrhosis")
|
Acceptable
|
|
GTEX-1N2EE
|
61-70
|
Male
|
GTEX-1N2EE-1426 |
Liver
|
PAXgene |
1
|
2 pieces, approaching score '2': diffuse severe macrovesicular steatosis
|
Acceptable
|
|
GTEX-1N2EF
|
61-70
|
Male
|
GTEX-1N2EF-1026 |
Liver
|
PAXgene |
2
|
2 pieces; severe central lobular vascular congestion and liver cell necrosis
|
Acceptable
|
|
GTEX-1N5O9
|
61-70
|
Male
|
GTEX-1N5O9-1626 |
Liver
|
PAXgene |
1
|
2 pieces; congestion; mild steatosis
|
Acceptable
|
|
GTEX-1N7R6
|
21-40
|
Female
|
GTEX-1N7R6-0826 |
Liver
|
PAXgene |
1
|
2 pieces; congestion; focal predominantly portal chronic inflammation
|
Acceptable
|
|
GTEX-1NV5F
|
61-70
|
Female
|
GTEX-1NV5F-0826 |
Liver
|
PAXgene |
2
|
2 pieces; nodular cirrhosis; centers of nodules are necrotic; 30% fibrous content; no normal tissue
|
Unacceptable
|
|
GTEX-1NV8Z
|
61-70
|
Male
|
GTEX-1NV8Z-1626 |
Liver
|
PAXgene |
1
|
2 pieces, mild passive congestion
|
Acceptable
|
|